The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation
Open accessAbstract
Background: Vagus nerve stimulation (VNS) is a recent intervention for treatment-resistant depression. Electrophysiological recordings in the rat brain showed that VNS increases the firing rate of norepinephrine (NE) neurons after 1 day of stimulation and that of serotonin (5-HT) neurons after 14 days. This study was conducted to further characterize these effects. Methods: We implanted rats with a VNS electrode and stimulator. We used the selective noradrenergic toxin DSP-4 to lesion NE neurons of the locus coeruleus. We recorded dorsal raphe 5-HT neurons under chloral hydrate anesthesia. We recorded hippocampus CA 3 pyramidal neurons using 5-barreled iontophoretic pipettes. Results: Analysis of a previously published data set revealed that VNS increased not only the spontaneous firing rates of NE neurons, but also the percentage of neurons firing in bursts. The enhancement of the 5-HT neuron firing rate by VNS was abolished by lesioning NE neurons. We found that VNS increased the degree of activation of postsynaptic α 1-adrenoceptors on 5-HT neurons, probably through an increased release of endogenous NE. The tonic activation of postsynaptic 5-HT 1A receptors in the hippocampus was enhanced after 14 days of VNS, as with other antidepressant treatments. Limitations: Our study limitations include the fact that we turned off the stimulator during the electrophysiological recordings, which likely decreased the vagal tone to the brain. Also, we obtained the data while the animals were under anesthesia, therefore studies need to be carried out in unanesthetized rats to ascertain whether the anesthetic agent influenced the changes observed between control rats and those treated with VNS. Conclusion: Vagus nerve stimulation initially increases the firing activity and pattern of NE neurons and subsequently those of 5-HT neurons, presumably as a cascade effect via α 1-postsynaptic adrenoceptors. To date, VNS appears to be a unique antidepressant treatment increasing 5-HT transmission and enhancing the firing activity of NE neurons. These effects could contribute to the effectiveness of VNS in treatment-resistant depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“These receptors appear to be important in the mediation of antidepressant effects.(13,14) In particular, long-term administration of various classes of antidepressants and repeated ECS leads to their enhanced tonic activation by 5-HT.”
BackgroundTwo-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
A review of functional neuroimaging studies of vagus nerve stimulation (VNS)
Chae, J.-H., Nahas, Z., Lomarev, M., Denslow, S., Lorberbaum, J. P., Bohning, D. E., & George, M. S. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00074-8 · Cited by 255
Vagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205
El Mansari, M., Ghanbari, R., Janssen, S., & Blier, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.028 · Cited by 63 · cited 1×
“It is noteworthy that sustained administration of the NE and dopamine releaser bupropion for 14 days significantly increases the percentage of both NE and 5-HT neurons discharging in bursts, but that only the mean firing rate of 5-HT neurons is significantly increased.(32,33) Therefore, whereas VNS and bupropion have…”
Background
Research works printed but not linked: 44
- Foley JO, 1937, J Comp Neurol, 67, 49, 10.1002/cne.900670104 · DOI · Paper page
- Buoni S, 2004, Brain Dev, 26, 158, 10.1016/S0387-7604(03)00120-7 · DOI
- Elger G, 2000, Epilepsy Res, 42, 203, 10.1016/S0920-1211(00)00181-9 · DOI · Paper page
- Schachter SC, 2004, Epilepsy Behav, 5, S56, 10.1016/j.yebeh.2003.11.007 · DOI
- Sackeim HA, 2001, Neuropsychopharmacology, 25, 713, 10.1016/S0893-133X(01)00271-8 · DOI · Paper page
- Marangell LB, 2002, Biol Psychiatry, 51, 280, 10.1016/S0006-3223(01)01343-9 · DOI · Paper page
- Krahl SE, 2004, J Psychiatr Res, 38, 237, 10.1016/j.jpsychires.2003.11.005 · DOI
- Daban C, 2008, J Affect Disord, 110, 1, 10.1016/j.jad.2008.02.012 · DOI · Paper page
- Pineyro G, 1999, Pharmacol Rev, 51, 533, 10.1016/S0031-6997(24)01417-0 · DOI · Paper page
- Blier P, 1994, Trends Pharmacol Sci, 15, 220, 10.1016/0165-6147(94)90315-8 · DOI · Paper page
- Haddjeri N, 1998, J Neurosci, 18, 10150, 10.1523/JNEUROSCI.18-23-10150.1998 · DOI · Paper page
- Svensson TH, 1975, Brain Res, 92, 291, 10.1016/0006-8993(75)90276-0 · DOI · Paper page
- Curet O, 1989, Brain Res, 499, 18, 10.1016/0006-8993(89)91131-1 · DOI
- Schoffelmeer AN, 1983, Naunyn Schmiedebergs Arch Pharmacol, 323, 188, 10.1007/BF00497661 · DOI
- Crews FT, 1978, Science, 202, 322, 10.1126/science.211589 · DOI · Paper page
- McMillen BA, 1980, Eur J Pharmacol, 61, 239, 10.1016/0014-2999(80)90126-0 · DOI · Paper page
- Vandermaelen CP, 1983, Brain Res, 289, 109, 10.1016/0006-8993(83)90011-2 · DOI · Paper page
- Millan MJ, 1994, J Pharmacol Exp Ther, 269, 121, 10.1016/S0022-3565(25)38665-9 · DOI
- Dorr AE, 2006, J Pharmacol Exp Ther, 318, 890, 10.1124/jpet.106.104166 · DOI · Paper page
- Grzanna R, 1989, J Histochem Cytochem, 37, 1435, 10.1177/37.9.2768812 · DOI
- Logue MP, 1985, Life Sci, 37, 403, 10.1016/0024-3205(85)90401-1 · DOI
- Aghajanian GK, 1982, J Neurosci, 2, 1786, 10.1523/JNEUROSCI.02-12-01786.1982 · DOI · Paper page
- Grace AA, 1984, J Neurosci, 4, 2877, 10.1523/JNEUROSCI.04-11-02877.1984 · DOI · Paper page
- Hajos M, 1995, Neuroscience, 69, 189, 10.1016/0306-4522(95)00227-A · DOI
- Kandel ER, 1961, J Neurophysiol, 24, 243, 10.1152/jn.1961.24.3.243 · DOI · Paper page
- Ranck JB, 1973, Exp Neurol, 41, 461, 10.1016/0014-4886(73)90290-2 · DOI · Paper page
- Florin-Lechner SM, 1996, Brain Res, 742, 89, 10.1016/S0006-8993(96)00967-5 · DOI · Paper page
- Ghanbari R, 2008, J Psychopharmacol
- Follesa P, 2007, Brain Res, 1179, 28, 10.1016/j.brainres.2007.08.045 · DOI · Paper page
- Roosevelt RW, 2006, Brain Res, 1119, 124, 10.1016/j.brainres.2006.08.048 · DOI · Paper page
- Gobbi G, 2007, Eur Neuropsychopharmacol, 17, 328, 10.1016/j.euroneuro.2006.07.004 · DOI
- Henry TR, 2002, Neurology, 59, S3
- Van Bockstaele EJ, 1999, J Comp Neurol, 412, 410, 10.1002/(SICI)1096-9861(19990927)412:3<410::AID-CNE3>3.0.CO;2-F · DOI · Paper page
- Ennis M, 1988, J Neurosci, 8, 3644, 10.1523/JNEUROSCI.08-10-03644.1988 · DOI · Paper page
- Ennis M, 1989, J Neurosci, 9, 2973, 10.1523/JNEUROSCI.09-08-02973.1989 · DOI · Paper page
- Cunningham JT, 2008, Neuropsychopharmacology, 33, 1884, 10.1038/sj.npp.1301570 · DOI · Paper page
- Bosker F, 1994, J Neurochem, 63, 2165, 10.1046/j.1471-4159.1994.63062165.x · DOI
- Hery F, 1986, Ann N Y Acad Sci, 473, 239, 10.1111/j.1749-6632.1986.tb23620.x · DOI
- Baraban JM, 1980, Neuropharmacology, 19, 355, 10.1016/0028-3908(80)90187-2 · DOI · Paper page
- Kasamo K, 2001, Neuropsychopharmacology, 24, 141, 10.1016/S0893-133X(00)00181-0 · doi:10.1016/s0893-133x(00)00181-0
- Besson A, 2000, Eur Neuropsychopharmacol, 10, 177, 10.1016/S0924-977X(00)00069-9 · DOI
- Szabo ST, 2001, Neuropsychopharmacology, 25, 845, 10.1016/S0893-133X(01)00284-6 · DOI
- Trulson ME, 1979, Brain Res, 163, 135, 10.1016/0006-8993(79)90157-4 · DOI · Paper page
- Haddjeri N, 2008, Eur J Pharmacol, 600, 64, 10.1016/j.ejphar.2008.10.001 · DOI
Cited by
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“Thus, VNS leads to an enhancement of the firing activity of NE neurons (93), and consequently, an increase in the firing activity of serotonin neurons (94).”
BackgroundYap, J. Y. Y., Keatch, C., Lambert, E., Woods, W., Stoddart, P. R., & Kameneva, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00284 · Cited by 432
Badran, B. W., Dowdle, L. T., Mithoefer, O. J., LaBate, N. T., Coatsworth, J., Brown, J. C., DeVries, W. H., Austelle, C. W., McTeague, L. M., & George, M. S. (2018) · Brain Stimulation · doi:10.1016/j.brs.2017.12.009 · Cited by 396
Farmer, A. D., Strzelczyk, A., Finisguerra, A., Gourine, A. V., Gharabaghi, A., Hasan, A., Burger, A. M., Jaramillo, A. M., Mertens, A., Majid, A., et al. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.568051 · Cited by 355
Hulsey, D. R., Riley, J. R., Loerwald, K. W., Rennaker, R. L., Kilgard, M. P., & Hays, S. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.12.005 · Cited by 313
Serotonin and beyond: therapeutics for major depression
Blier, P., & El Mansari, M. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0536 · Cited by 257
Self-citationVagal nerve stimulation for treatment-resistant depression
Carreno, F. R., & Frazer, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0537-8 · Cited by 208
Manta, S., El Mansari, M., Debonnel, G., & Blier, P. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000387 · Cited by 192
Self-citationPeña, D. F., Childs, J. E., Willett, S., Vital, A., McIntyre, C. K., & Kroener, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00327 · Cited by 165
The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus
O’Leary, O. F., Ogbonnaya, E. S., Felice, D., Levone, B. R., C. Conroy, L., Fitzgerald, P., Bravo, J. A., Forsythe, P., Bienenstock, J., Dinan, T. G., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.004 · Cited by 151
Noble, L. J., Gonzalez, I. J., Meruva, V. B., Callahan, K. A., Belfort, B. D., Ramanathan, K. R., Meyers, E., Kilgard, M. P., Rennaker, R. L., & McIntyre, C. K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.191 · Cited by 121
Furmaga, H., Shah, A., & Frazer, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.020 · Cited by 116
Kemp, A. H., Koenig, J., & Thayer, J. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.006 · Cited by 114
MacKinnon, S., Gevirtz, R., McCraty, R., & Brown, M. (2013) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-013-9226-5 · Cited by 87
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
Shin, H. C., Jo, B. G., Lee, C., Lee, K., & Namgung, U. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14368 · Cited by 56
Mercante, B., Enrico, P., Floris, G., Quartu, M., Boi, M., Serra, M. P., Follesa, P., & Deriu, F. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.012 · Cited by 43
Rizvi, S. J., Donovan, M., Giacobbe, P., Placenza, F., Rotzinger, S., & Kennedy, S. H. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.630993 · Cited by 42
Liu, H., Liu, Y., Yu, J., Lai, M., Zhu, H., Sun, A., Chen, W., & Zhou, W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.059 · Cited by 40
The beneficial effects of meditation: contribution of the anterior cingulate and locus coeruleus.
Craigmyle, N. A. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00731 · Cited by 32
Metadata
- Authors
- Manta, S., Dong, J., Debonnel, G., & Blier, P.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2009-07
- Volume
- 34
- Issue
- 4
- Pages
- 272-280
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W4413981339
- Cited by
- 217
- References
- 5
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.